Skip to content

Validation of novel, accelerated and artifact-resistant techniques in whole-body magnetic resonance imaging

Validation of novel, accelerated and artifact-resistant techniques in whole-body magnetic resonance imaging

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00023278
Enrollment
800
Registered
2020-10-08
Start date
2020-10-01
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers and patients are examined. A wide variety of diseases / health problems are examined in patients. The most important criterion is a clinically indicated MRI examination.

Interventions

Group 1: In healthy subjects: Evaluation of MRI sequences and sequence order with regard to parameterization of the sequences, image quality and potential clinical application. Group 2: For patients:

Sponsors

Universitätsklinikum Tübingen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Healthy subjects: - Healthy adults (male or female), - Age: 18-60 years, - Letter of acceptance (informed consent). Patients: - male and female patients, - Age: 18-85 years, - Letter of acceptance (informed consent), - Carrying out a clinically indicated MRI examination as part of clinical routine (no study-related intervention).

Exclusion criteria

Exclusion criteria: Healthy subjects: - MRI contraindications, - pregnancy / lactation, - claustrophobia, - Lack of consent to the communication of incidental findings. Patients: - MRI contraindications, - pregnancy / lactation, - Claustrophobia.

Design outcomes

Primary

MeasureTime frame
The aim of this research project is the evaluation of new, accelerated and robust MR-technologies with regard to their technical maturity and their information content. For this purpose, various MRI-techniques are to be used first on healthy volunteers and then on patients.

Secondary

MeasureTime frame
Quality assurance, reduction of MRI measurement times

Countries

Germany

Contacts

Public ContactJudith Herrmann

Universitätsklinikum Tübingen, Radiologische Klinik, Abt. für Diagnostische & Interventionelle Radiologie

judith.herrmann@med.uni-tuebingen.de07071-2968053

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 11, 2026